Kestra Medical Technologies Reports Officer/Director Changes
Ticker: KMTS · Form: 8-K · Filed: Jun 6, 2025 · CIK: 1877184
| Field | Detail |
|---|---|
| Company | Kestra Medical Technologies, LTD. (KMTS) |
| Form Type | 8-K |
| Filed Date | Jun 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: officer-changes, director-changes, compensation
TL;DR
Kestra Medical (KMTX) filed an 8-K detailing director/officer changes and compensatory arrangements.
AI Summary
Kestra Medical Technologies, Ltd. filed an 8-K on June 6, 2025, reporting events as of June 4, 2025. The filing indicates changes related to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. It also includes financial statements and exhibits.
Why It Matters
Changes in key personnel and officer appointments can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in board composition and officer appointments can introduce uncertainty regarding future strategy and leadership stability.
Key Players & Entities
- KESTRA MEDICAL TECHNOLOGIES, LTD. (company) — Registrant
- June 4, 2025 (date) — Earliest event reported
- June 6, 2025 (date) — Date of report
- 001-42549 (company) — Commission File Number
FAQ
What specific changes occurred regarding directors or officers?
The filing indicates events related to the departure of directors or certain officers, election of directors, and appointment of certain officers.
Are there any details on new compensatory arrangements?
Yes, the filing mentions compensatory arrangements of certain officers as an item of information.
What is the primary business of Kestra Medical Technologies?
Kestra Medical Technologies, Ltd. is in the business of Surgical & Medical Instruments & Apparatus, SIC code 3841.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 4, 2025.
What is the company's principal executive office address?
The principal executive offices are located at 3933 Lake Washington Blvd NE, Suite 200, Kirkland, Washington 98033.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 regarding KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS).